PlainRecalls
FDA Drug Critical Class I Terminated

Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per carton, Distributed by AuroMedics Pharma LLC. 279 Princeton-Highstown Rd. E. Windsor, NJ 08520, NDC 55150-116-20

Reported: February 14, 2018 Initiated: January 2, 2018 #D-0339-2018

Product Description

Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per carton, Distributed by AuroMedics Pharma LLC. 279 Princeton-Highstown Rd. E. Windsor, NJ 08520, NDC 55150-116-20

Reason for Recall

Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.

Details

Recalling Firm
Aurobindo Pharma Ltd.
Units Affected
53,040 vials
Distribution
distributed nationwide in the USA
Location
Hyderabad, N/A

Frequently Asked Questions

What product was recalled?
Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per carton, Distributed by AuroMedics Pharma LLC. 279 Princeton-Highstown Rd. E. Windsor, NJ 08520, NDC 55150-116-20. Recalled by Aurobindo Pharma Ltd.. Units affected: 53,040 vials.
Why was this product recalled?
Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 14, 2018. Severity: Critical. Recall number: D-0339-2018.